Corporate News
11 September 2023
A major bottleneck in drug discovery, particularly when targeting transmembrane proteins such as G-coupled receptor proteins (GPCRs), is the challenge of replicating in vitro the precise microenvironment conditions […]
7 July 2023
Our portfolio of #GPCR#fluorescent ligands is growing.We have just added to our catalogue more fluorescent ligands for the AT1 receptor, CELT-145 and CELT-252. The Angiotensin AT1 receptor belongs to the […]
27 March 2023
Celtarys Research collaborates with several research groups in Europe for the validation of our products in different assays commonly used in drug discovery, always with the […]
3 March 2023
Our portfolio of #GPCR#fluorescent ligands is growingWe have just added to our catalogue more fluorescent ligands for the C5a receptor, CELT-58 and CELT-68. The C5a anaphylatoxin chemotactic receptor 1 (C5aR, also […]
19 December 2022
We are glad to announce that Celtarys Research has reached a strategic research cooperation agreement with the European platform EU-OPENSCREEN (https://www.eu-openscreen.eu ), a not-for-profit European Research Infrastructure […]
9 November 2022
The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Granada, Spain, on November 24 and 25, 2022. This international conference has […]
20 September 2022
To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
26 July 2022
The ONCOMET group from the Health Research Institute of Santiago led by Dr. Miguel Abal has published an interesting article showing tumor and stromal-specific genetic signatures […]
15 July 2022
We are proud to announce our new collaboration with the marketplace company Chemspace for the distribution of our exclusive GPCR fluorescent probes. Chemspace is the largest […]